1. Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway
   Ping Yang et al, 2017, Toxicology Letters CrossRef
2. Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
   Xingchun Gao et al, 2017, Frontiers in Immunology CrossRef
3. Lymphoid Interstitial Pneumonia in Common Variable Immune Deficiency – Case Report With Disease Monitoring in Various Therapeutic Options: Pleiotropic Effects of Rituximab Regimens
   Przemyslaw Zdziarski et al, 2019, Frontiers in Pharmacology CrossRef
4. Novel TLR7 agonist stimulates activity of CIK/NK immunological effector cells to enhance antitumor cytotoxicity
   Dong Gao et al, 2018, Oncology Letters CrossRef
5. Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim
   Ka‐Won Kang et al, 2020, Cancer Medicine CrossRef
6. Promising immunotherapy: Highlighting cytokine‐induced killer cells
   Solmaz Shirjang et al, 2019, Journal of Cellular Biochemistry CrossRef